24/7 Patient Assistance: 760-405-8205

After treatment with gemcitabine hydrochloride, approximately 50% of patients experienced partial remission for an average period of 6 months.

U N C O M M O N   side effects

Gemcitabine

(Lung Cancer, Ovarian Cancer)

Gemcitabine hydrochloride is injected intravenously over the course of 30 minutes.

C O M M O N   side effects